Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
Clinical trial NCT04912427 · TERMINATED
Trial details
- NCT number
- NCT04912427
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2022-12-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.